For much of the past few years, CVS was treated as a problem stock. But new earnings show a promised comeback is actually ...

CVS Health earnings came in ahead of analyst forecasts but the company is concerned about Medicare rates.

Recent Medicare Advantage news may mean disappointing updates to guidance.

Compared to the aggregate P/E ratio of 81.17 in the Health Care Providers & Services industry, CVS Health Inc. has a higher P/E ratio of 200.87. Shareholders might be inclined to think that CVS Health ...

CVS Health remains well-positioned despite a sector-wide selloff after disappointing Medicare rate increases and UnitedHealth ...

Medicare Advantage rates may not be going up as much as expected in 2027, and that has investors concerned about CVS Health.

CVS Health CVS is scheduled to report third-quarter 2025 results on Oct. 29, before the market opens. The Zacks Consensus Estimate for third-quarter earnings per share (EPS) suggests a 24.8% increase ...

CVS' Q4 2025 saw record revenue, but rising medical costs in Aetna drove a $1B cut to FY 2026 cash flow guidance, now at $9B.

CVS Health has been a volatile investment to own in recent years, skyrocketing in 2025 after crashing in 2024. Rising costs have been weighing on investors' minds, but CVS has been doing better than ...